Consistent with our prediction, previous studies [90–92] have shown that therapeutic elevation of selenium in 3xTg-AD mice, which express mutant PS1 in addition to mutant APP and tau, effectively combats hippocampal-dependent learning and memory impairments, as well as behavioral phenotypes. Here, MAPT is linked to Alzheimer disease.